Literature DB >> 10506102

Alterations of SAG mRNA in human cancer cell lines: requirement for the RING finger domain for apoptosis protection.

Y Sun1.   

Abstract

We have recently cloned and characterized a novel zinc RING finger gene, SAG (sensitive to apoptosis gene). SAG has antioxidant activity and protects cells from apoptosis induced by metal ions and redox compounds. During the course of SAG cloning, we identified two forms of deletions of SAG mRNA in colon and testicular carcinoma cell lines. The first form (SAG-MU1) consists of a 7 bp deletion that results in a frameshift and abolishes the RING finger domain. The second (SAG-MU2) consists of an in-frame 48 bp deletion that truncates 16 amino acids in the protein but retains the RING finger domain. Functional studies using stable transfectant lines reveal that, like wild-type SAG, SAG-MU2 retains anti-apoptosis activity, whereas SAG-MU1 shows no such protection. The results indicate that the C-terminal zinc RING finger domain is required for anti-apoptosis activity of SAG.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10506102     DOI: 10.1093/carcin/20.10.1899

Source DB:  PubMed          Journal:  Carcinogenesis        ISSN: 0143-3334            Impact factor:   4.944


  15 in total

1.  CK2 phosphorylation of SAG at Thr10 regulates SAG stability, but not its E3 ligase activity.

Authors:  Hongbin He; Mingjia Tan; Deepika Pamarthy; Guixia Wang; Khalil Ahmed; Yi Sun
Journal:  Mol Cell Biochem       Date:  2006-07-28       Impact factor: 3.396

2.  SAG/ROC-SCF beta-TrCP E3 ubiquitin ligase promotes pro-caspase-3 degradation as a mechanism of apoptosis protection.

Authors:  Mingjia Tan; Jayme R Gallegos; Qingyang Gu; Yuanhui Huang; Jun Li; Yetao Jin; Hua Lu; Yi Sun
Journal:  Neoplasia       Date:  2006-12       Impact factor: 5.715

3.  SAG/RBX2/ROC2 E3 ubiquitin ligase is essential for vascular and neural development by targeting NF1 for degradation.

Authors:  Mingjia Tan; Yongchao Zhao; Sun-Jung Kim; Margaret Liu; Lijun Jia; Thomas L Saunders; Yuan Zhu; Yi Sun
Journal:  Dev Cell       Date:  2011-11-23       Impact factor: 12.270

Review 4.  E3 ubiquitin ligases as cancer targets and biomarkers.

Authors:  Yi Sun
Journal:  Neoplasia       Date:  2006-08       Impact factor: 5.715

5.  Small RING Finger Proteins RBX1 and RBX2 of SCF E3 Ubiquitin Ligases: The Role in Cancer and as Cancer Targets.

Authors:  Dongping Wei; Yi Sun
Journal:  Genes Cancer       Date:  2010-07

Review 6.  SCF E3 ubiquitin ligases as anticancer targets.

Authors:  L Jia; Y Sun
Journal:  Curr Cancer Drug Targets       Date:  2011-03       Impact factor: 3.428

7.  Disruption of Sag/Rbx2/Roc2 induces radiosensitization by increasing ROS levels and blocking NF-kappaB activation in mouse embryonic stem cells.

Authors:  Mingjia Tan; Yueming Zhu; Jordan Kovacev; Yongchao Zhao; Zhen-Qiang Pan; Douglas R Spitz; Yi Sun
Journal:  Free Radic Biol Med       Date:  2010-06-08       Impact factor: 7.376

8.  Radiosensitization of Cancer Cells by Inactivation of Cullin-RING E3 Ubiquitin Ligases.

Authors:  Dongping Wei; Meredith A Morgan; Yi Sun
Journal:  Transl Oncol       Date:  2012-10-01       Impact factor: 4.243

Review 9.  Functional characterization of SAG/RBX2/ROC2/RNF7, an antioxidant protein and an E3 ubiquitin ligase.

Authors:  Yi Sun; Hua Li
Journal:  Protein Cell       Date:  2012-11-08       Impact factor: 14.870

10.  Validation of SAG/RBX2/ROC2 E3 ubiquitin ligase as an anticancer and radiosensitizing target.

Authors:  Lijun Jia; Jie Yang; Xinbao Hao; Min Zheng; Hongbin He; Xiufang Xiong; Liang Xu; Yi Sun
Journal:  Clin Cancer Res       Date:  2010-01-26       Impact factor: 12.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.